Page 49 - Read Online
P. 49

Page 10 of 11                                           Stier et al. Mini-invasive Surg 2020;4:18  I  http://dx.doi.org/10.20517/2574-1225.2019.75


               This study is limited by the retrospective nature of the data analysis. In addition, the data were collected
               in a single-centre study, although 3D-CT is a well-established diagnostic tool in this high-volume certified
               centre of excellence for obesity and metabolic surgery.

               To conclude, 3D-CT is quick, easy-to-perform and facilitates identification of the post-surgical gastric
               anatomy. It represents a valuable additional diagnostic tool in post-bariatric patients with post-procedural
               complications, since UE and UGI might miss the three-dimensional post-bariatric anatomy. 3D-CT might
               be an important preoperative tool prior to revisional surgery and an ideal diagnostic complement in
               patients with post-surgical complications following obesity surgery.


               DECLARATIONS
               Authors’ contributions
               Designed the article: Stier C, Chiappetta S
               Calculated the statistics and proofed the concept: Parmar C, Koschker AC, Stier R
               Operating radiologist: Bokhari M

               Availability of data and materials
               Data route from the results of routine examinations of patients. Anonymized data sheet is available from
               the authors (Stier C).

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               All procedures performed in this study involving human participants were in accordance with the ethical
               standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration
               and its later amendments or comparable ethical standards.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle,
                   diabetes, and cardio- vascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.
               2.   Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year
                   outcomes. N Engl J Med 2017;376:641-51.
               3.   Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, et al. Bariatric-metabolic surgery versus conventional medical
                   treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet
                   2015;386:964-73.
               4.   Healy P, Clarke C, Reynolds I, Arumugasamy M, McNamara D. Complications of bariatric surgery--What the general surgeon needs to
                   know. Surgeon 2016;14:91-8.
               5.   Livingston EH. Complications of bariatric surgery. Surg Clin North Am 2005;85:853-68.
               6.   Abd Ellatif ME, Alfalah H, Asker WA, El Nakeeb AE, Magdy A, et al. Place of upper endoscopy before and after bariatric surgery: a
                   multicenter experience with 3219 patients. World J Gastrointest Endosc 2016;8:409-17.
               7.   Brethauer SA, Nfonsam V, Sherman V, Udomsawaengsup S, Schauer PR, et al. Endoscopy and upper gastrointestinal contrast studies
   44   45   46   47   48   49   50   51   52   53   54